Sagimet Biosciences Inc.
SGMT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001400118
In the last 90 days, Sagimet Biosciences Inc. insiders filed 0 open-market purchases and 5 sales; 122 institutions reported holding it in 13F filings for Q2 2026, worth $394.3M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Sagimet Biosciences Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 82
- +1 vs. Q1 2024
- Shares held
- 20.9M
- −1.68M (−7.4%) vs. Q1 2024
- Total value
- $71.6M
- −$51.0M (−41.6%) vs. Q1 2024
- New holders
- 22
- 22 more added
- Sold out
- 21
- 21 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGMT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $394.3M |
| Q1 2026 | 88 | $69.8M |
| Q4 2025 | 86 | $85.2M |
| Q3 2025 | 72 | $86.7M |
| Q2 2025 | 67 | $89.0M |
| Q1 2025 | 70 | $44.9M |
| Q4 2024 | 66 | $78.8M |
| Q3 2024 | 63 | $54.4M |
| Q2 2024 | 82 | $71.6M |
| Q1 2024 | 81 | $122.5M |
| Q4 2023 | 51 | $76.1M |
| Q3 2023 | 48 | $130.2M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Sagimet Biosciences Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −525−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |